55.49
-0.47%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Ramsay Health Care
Its shares trade on ASX under the ticker RHC.AX. It has been listed since 24 September 1997. In the fiscal year to 30 June 2026, it reported revenue of A$18.58bn and net income of A$329.2m. At that date it held total assets of A$21.17bn and shareholders' equity of A$4.96bn.
Ramsay Health Care Ltd. engages in the provision of healthcare services and the operation of hospitals and day surgery facilities. The company is headquartered in Macquarie, New South Wales. Its segments are Asia Pacific, UK, France and Nordics. The company operates approximately 500 hospitals and day surgery facilities across Australia, the United Kingdom, France, Sweden, Norway, Denmark, Germany, Indonesia, Malaysia, Hong Kong and Italy. Its facilities cater for a range of healthcare needs from day surgery procedures to complex surgery, as well as psychiatric care and rehabilitation. In Australia, it operates approximately 73 hospitals and day surgery units. In the United Kingdom, the Company provides independent hospital services in the United Kingdom, with a network of over 30 acute hospitals and day procedure centers providing a range of clinical specialties to private and self-insured patients, as well as to patients referred by the National Health Service. In the United Kingdom, it also operates a diagnostic imaging service and provides neurological services through its neuro-rehabilitation facilities.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 24 Sept 1997
- Employees
- 80,000
- Website
- ramsayhealth.com ↗
Leadership
Pay as last reported
- Mr. David ThodeyNon-Executive Independent Chairman of the BoardA$502,513
- Ms. Natalie DavisChief Executive Officer, Managing Director, Executive Director, since 2024
- Mr. Martyn RobertsGroup Chief Financial OfficerA$1.7m
- Ms. Henrietta RoweGroup General Counsel, Company Secretary
- Ms. Helen KurincicNon-Executive Director$91,899
- Mr. Michael SiddleNon-Executive DirectorA$430,560
- Ms. Alison DeansNon-Executive Independent DirectorA$291,415
- Dr. Claudia DyckerhoffNon-Executive Independent DirectorA$292,563
- Mr. James McMurdoNon-Executive Independent DirectorA$275,700
- Ms. Karen PenroseNon-Executive Independent DirectorA$312,497
- Mr. Steven SargentNon-Executive Independent DirectorA$298,761
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 93
- Environment
- 98
- Social
- 99
- Governance
- 81
- Direct emissions (scope 1)
- 90,260 t
- Energy emissions (scope 2)
- 155,223 t
- Value chain emissions (scope 3)
- 8,174 t
- Women in the workforce
- 78.87178%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Leading healthcare company with a global presence and extensive network.
- Strong brand reputation for providing high-quality medical services.
- Diversified portfolio of healthcare facilities, including hospitals, day surgeries, and rehabilitation centers.
- Robust financial performance and steady revenue growth.
Weaknesses
- Reliance on government funding for a significant portion of revenue.
- Vulnerability to healthcare regulations and policies in different countries.
- Limited presence in emerging markets compared to competitors.
- Possible challenges in adapting to rapidly evolving healthcare technologies.
Opportunities
- Increasing demand for healthcare services, driven by aging populations and rising healthcare awareness.
- Expansion into emerging markets with untapped potential for private healthcare providers.
- Strategic partnerships and acquisitions to enhance service offerings and geographic reach.
- Growing trend of medical tourism, attracting patients from different countries.
Threats
- Intense competition from local and international healthcare providers.
- Economic downturns leading to reduced healthcare spending.
- Increased regulatory scrutiny and compliance requirements.
- Potential disruptions due to public health crises or natural disasters.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.